Lv51
890 积分 2024-06-17 加入
Macrophage-specific PHGDH protects against MAFLD by suppressing TAK1
5小时前
已完结
Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11
5小时前
已完结
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
5小时前
已完结
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
5小时前
已完结
Mitochondrial targeted therapy in MAFLD
5小时前
已完结
Review of current and new drugs for the treatment of metabolic-associated fatty liver disease
12天前
已完结
The first MASH drug therapy on the horizon: Current perspectives of resmetirom
12天前
已完结
Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11
12天前
已完结
Prevalence and risk factors of significant Fibrosis in CHB patients with concurrent MASLD
1个月前
已完结
NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study
1个月前
已完结
皖公网安备34019202002308
